XML 56 R43.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Noncontrolling Interest (Details Textual) - USD ($)
12 Months Ended
Dec. 30, 2015
Dec. 17, 2012
Dec. 31, 2016
Dec. 31, 2015
Proceeds from Issuance or Sale of Equity     $ 750,000
Consulting Services, Monthly Payment $ 23,438      
Consulting Services, Period of Services 4 years      
Net Income (Loss) Attributable to Noncontrolling Interest     (234,604) (21,054)
Clyra Medical Technology Inc [Member]        
Sale of Stock, Percentage of Ownership after Transaction 54.00%      
Clyra Medical Technology Inc [Member]        
Investment Owned, Balance, Shares   7,500    
Preferred Stock, Dividend Rate, Percentage 8.00%      
Preferred Shares Dividend, Period 5 years      
Dividends Payable     60,000  
Net Income (Loss) Attributable to Noncontrolling Interest     $ 508,414 $ 115,859
Clyra Medical Technology Inc [Member] | Series A Preferred Stock [Member] | Sanatio [Member]        
Sale of Stock, Number of Shares Issued in Transaction 9,830      
Proceeds from Issuance or Sale of Equity $ 750,000      
Clyra Medical Technology Inc [Member] | Each of 3 Individuals [Member]        
Stock Issued During Period, Shares, New Issues   1,500    
Sanatio [Member] | Clyra Medical Technology Inc [Member]        
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners 40.00%